Clinical outcomes after alloBMT are associated with number of CH mutations with variant allele frequencies >1%. Kaplan-Meier curves of (A) OS and (B) PFS; cumulative incidence of (C) NRM and (D) relapse by CH-negative and number of mutations (single mutation, 2 or more mutations).